CP-358,774
Jump to navigation
Jump to search
| CP-358,774 | |
|---|---|
| Term | CP-358,774 |
| Short definition | CP-358,774 - A drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
CP-358,774 - A drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. CP-358. 774 blocks a protein called EGFR, which may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774 and Tarceva
External links
- Medical encyclopedia article on CP-358,774
- Wikipedia's article - CP-358,774
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski